Everolimus
38 NDCs across 9 manufacturers|35 Generic,3 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 30, 2009, and the first generic was approved Apr 12, 2018. FDA's Orange Book lists 72 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $165 million on Everolimus across 42,000 claims for 7,547 beneficiaries.
Everolimus is available as 38 NDCs from 9 manufacturers (35 generic, 3 brand), with NADAC prices from $1.79 to $462.04 per EA — the most expensive product costs about 259× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
38
35G / 3B
Manufacturers
9
competing in market
Price Spread
$1.79 – $462.04
per EA
7d Activity
avg -6.9% WoW · of 38 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Biocon Pharma Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Kinase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
9 manufacturers producing EVEROLIMUS(1 pricing outlier)
Frequently Asked Questions
When did Everolimus become available as a generic?
FDA approved the first generic Everolimus (ANDA) on Apr 12, 2018. The Orange Book currently lists 72 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Everolimus?
In 2024, Medicare Part D spent $165 million on Everolimus across 42,000 claims for 7,547 beneficiaries.
How many Everolimus products are on the market?
The Everolimus drug market contains 38 NDCs from 9 manufacturers — 35 generic and 3 brand products.
What is the price range for Everolimus?
NADAC reference prices for Everolimus range from $1.7852 to $462.0394 per EA — the most expensive product costs about 259× the cheapest.
Is generic Everolimus cheaper than brand?
The average generic NADAC for Everolimus is $12.6745 per EA, versus $168.9618 for brand-labeled products — brand versions average about 13× the generic price.
Which manufacturers make Everolimus?
9 manufacturers list Everolimus in NADAC. Ranked by number of NDCs, the largest are Biocon Pharma Inc. (10), Hikma Pharmaceuticals USA Inc. (6), Par Health USA, LLC (5), Breckenridge Pharmaceutical Inc. (4), Ascend Laboratories, LLC (4).
How has the price of Everolimus changed recently?
Over the past 7 days, 0 Everolimus NDCs rose and 32 fell, with a market-wide average change of -6.9%.